Daniel Callahan, PA-C
NPI: 1265998439
Total Payments
$5,590
2024 Payments
$1,489
Companies
34
Transactions
326
Medicare Patients
565
Medicare Billing
$44,337
Payment Breakdown by Category
Food & Beverage$5,590 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,590 | 326 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,098 | 84 | $0 (2024) |
| Novo Nordisk Inc | $590.80 | 35 | $0 (2024) |
| Lilly USA, LLC | $582.40 | 36 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $579.28 | 31 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $464.92 | 23 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $249.13 | 6 | $0 (2023) |
| PFIZER INC. | $247.84 | 15 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $171.53 | 6 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $168.74 | 9 | $0 (2024) |
| Lundbeck LLC | $156.65 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,489 | 89 | Lilly USA, LLC ($307.95) |
| 2023 | $1,172 | 76 | ABBVIE INC. ($261.61) |
| 2022 | $1,416 | 74 | ABBVIE INC. ($290.57) |
| 2021 | $1,514 | 87 | AbbVie Inc. ($298.99) |
All Payment Transactions
326 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $18.12 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.72 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.14 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Obesity | ||||||
| 11/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $5.80 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $22.13 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.45 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: VACCINE | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Bone Health | ||||||
| 10/10/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.93 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.30 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.46 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/28/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $23.14 | General |
| 08/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 133 | 187 | $43,791 | $12,116 |
| 2022 | 5 | 132 | 166 | $33,976 | $9,111 |
| 2021 | 5 | 156 | 226 | $50,771 | $14,390 |
| 2020 | 5 | 144 | 184 | $37,825 | $8,721 |
Total Patients
565
Total Services
763
Medicare Billing
$44,337
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 92 | $24,840 | $6,336 | 25.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 25 | 25 | $8,550 | $2,767 | 32.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 37 | $6,771 | $1,808 | 26.7% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 26 | 33 | $3,630 | $1,205 | 33.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 62 | $16,740 | $3,817 | 22.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 19 | 19 | $6,498 | $2,118 | 32.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 37 | $6,771 | $1,927 | 28.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 28 | 35 | $3,850 | $1,219 | 31.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 11 | 13 | $117.00 | $28.88 | 24.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 53 | 101 | $27,270 | $7,314 | 26.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 44 | 44 | $15,048 | $4,977 | 33.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 29 | 39 | $7,137 | $1,929 | 27.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 12 | 14 | $1,064 | $106.68 | 10.0% |
| 81003 | Automated urinalysis test | Office | 2021 | 18 | 28 | $252.00 | $63.00 | 25.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 67 | 93 | $17,019 | $3,777 | 22.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 25 | 25 | $8,550 | $2,482 | 29.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 25 | 36 | $9,720 | $1,665 | 17.1% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 11 | 11 | $2,365 | $754.52 | 31.9% |
| 81003 | Automated urinalysis test | Office | 2020 | 16 | 19 | $171.00 | $42.45 | 24.8% |
About Daniel Callahan, PA-C
Daniel Callahan, PA-C is a Student in an Organized Health Care Education/Training Program healthcare provider based in Peachtree City, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2019. The National Provider Identifier (NPI) number assigned to this provider is 1265998439.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Callahan, PA-C has received a total of $5,590 in payments from pharmaceutical and medical device companies, with $1,489 received in 2024. These payments were reported across 326 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($5,590).
As a Medicare-enrolled provider, Callahan has provided services to 565 Medicare beneficiaries, totaling 763 services with total Medicare billing of $44,337. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Physician Assistant
- Location Peachtree City, GA
- Active Since 02/13/2019
- Last Updated 09/25/2019
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1265998439
Products in Payments
- VRAYLAR (Drug) $678.53
- REXULTI (Drug) $604.11
- FARXIGA (Drug) $446.12
- NURTEC ODT (Drug) $356.81
- MOUNJARO (Drug) $293.53
- Ozempic (Drug) $250.41
- UBRELVY (Drug) $250.25
- TRULICITY (Drug) $234.48
- JARDIANCE (Drug) $230.83
- QULIPTA (Drug) $168.73
- XIFAXAN (Drug) $129.32
- SOLIQUA 100/33 (Biological) $122.38
- AIRSUPRA (Drug) $117.16
- Rybelsus (Drug) $115.65
- SHINGRIX (Biological) $112.18
- JORNAY PM (Drug) $98.80
- Saxenda (Drug) $95.52
- Livalo (Drug) $87.03
- NEXLETOL (Drug) $67.15
- COLOGUARD DNA CAPTURE REAGENTS (Device) $55.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Peachtree City
Sumana Reddy
Student in an Organized Health Care Education/Training Program — Payments: $2,781
Student in an Organized Health Care Education/Training Program $2,781
Dr. Ruby Appiah, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $375.08
Student in an Organized Health Care Education/Training Program $375.08
Dr. Richelle Gonzalez-Brown, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $191.09
Student in an Organized Health Care Education/Training Program $191.09
Kelly Peronti, Agacnp-Bc, AGACNP-BC
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Miss. Madison Highland
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Christopher Velez Reyes, Md, MD
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program